financetom
Business
financetom
/
Business
/
Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug's autism risks
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug's autism risks
Oct 28, 2025 6:46 AM

(Reuters) -The makers of Tylenol, Johnson & Johnson ( JNJ ) and Kenvue, were sued on Tuesday by Texas Attorney General Ken Paxton, who accused them of knowingly hiding the drug's links to autism and attention deficit hyperactivity disorder.

Paxton, a Republican, sued five weeks after Republican President Donald Trump said using Tylenol during pregnancy can cause autism in children. Trump is not a doctor, and his claim is unproven and not backed by scientific evidence.

Johnson & Johnson ( JNJ ) sold Tylenol for more than six decades, and its former Kenvue unit has sold it since 2023 after being spun off. The pain reliever is known generically as acetaminophen.

Kenvue has repeatedly defended Tylenol's safety, and in a statement said it would defend against Paxton's lawsuit.

"Acetaminophen is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy," Kenvue said. "We are deeply concerned by the perpetuation of misinformation on the safety of acetaminophen."

In a separate statement, Johnson & Johnson ( JNJ ) did not comment on Paxton's lawsuit, and said Kenvue is responsible for "all rights and liabilities associated with the sale of its over-the-counter products, including Tylenol."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Intel to spin off its venture capital arm
Intel to spin off its venture capital arm
Jan 14, 2025
Jan 14 (Reuters) - Chipmaker Intel Corp said on Tuesday that it will separate its venture capital and investment arm, Intel Capital, into a standalone company, to focus on enhancing efficiency across the business. Intel ( INTC ), which will remain an anchor investor, said the standalone operations are expected to begin in the second half of 2025 and will...
Bayer must pay $100 million in latest trial over PCBs in Washington school, jury finds
Bayer must pay $100 million in latest trial over PCBs in Washington school, jury finds
Jan 14, 2025
* Bayer argues PCB levels were safe, blames school for ignoring warnings * Previous trials resulted in over $1.5 billion in verdicts By Brendan Pierson and Dietrich Knauth January 14 (Reuters) - A Washington state jury on Tuesday said Bayer must pay $100 million to four people who say they were sickened by exposure to toxic chemicals known as PCBs...
Warner Bros. Discovery Adds Anthony Noto, Joey Levin To Board, Shares Tick Higher
Warner Bros. Discovery Adds Anthony Noto, Joey Levin To Board, Shares Tick Higher
Jan 14, 2025
Warner Bros. Discovery Inc ( WBD ) shares are inching higher in extended trading Tuesday after the company added two new board members. What Happened: After the market close on Tuesday, Warner Bros. Discovery ( WBD ) announced that SoFi Technologies Inc ( SOFI ) CEO Anthony Noto and newly appointed Angi Inc ( ANGI ) Executive Chair Joey Levin...
Intel to spin off its venture capital arm
Intel to spin off its venture capital arm
Jan 14, 2025
(Reuters) - Chipmaker Intel Corp said on Tuesday that it will separate its venture capital and investment arm, Intel Capital, into a standalone company, to focus on enhancing efficiency across the business. Intel ( INTC ), which will remain an anchor investor, said the standalone operations are expected to begin in the second half of 2025 and will have a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved